| Title |
A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
|
|---|---|
| Published in |
Surgical Case Reports, November 2022
|
| DOI | 10.1186/s40792-022-01561-z |
| Pubmed ID | |
| Authors |
Keita Hanada, Shigeru Tsunoda, Motoo Nomura, Shintaro Fujimura, Yojiro Yutaka, Tatsuto Nishigori, Shigeo Hisamori, Hisatsugu Maekewa, Nobuaki Hoshino, Atsushi Itami, Eiji Tanaka, Kazutaka Obama |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2022.
All research outputs
#16,845,748
of 24,770,025 outputs
Outputs from Surgical Case Reports
#97
of 535 outputs
Outputs of similar age
#250,429
of 435,125 outputs
Outputs of similar age from Surgical Case Reports
#5
of 24 outputs
Altmetric has tracked 24,770,025 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 535 research outputs from this source. They receive a mean Attention Score of 1.0. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,125 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.